companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories














  • Discover a Treatment Option | NUCALA (mepolizumab)
    Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)— NUCALA is a prescription medicine for add-on maintenance treatment of CRSwNP in adults whose disease is not controlled with nasal corticosteroids
  • Nucala: Uses, Dosage, Side Effects - Drugs. com
    Nucala is used to treat severe eosinophilic asthma, eosinophilic COPD, chronic rhinosinusitis with nasal polyps (CRSwNP), eosinophilic granulomatosis with polyangiitis (EGPA), and hypereosinophilic syndrome (HES)
  • Discover a Treatment Option | NUCALA (mepolizumab) for HCPs
    NUCALA is a humanized IL-5 antagonist monoclonal antibody that binds to IL-5 and blocks its binding to the alpha chain of the IL-5 receptor complex on the eosinophil cell surface
  • Nucala (mepolizumab) approved by US FDA for use in adults with chronic . . .
    Nucala is a monoclonal antibody that targets and binds to interleukin-5 (IL-5), a key messenger protein (cytokine) in type 2 inflammation Nucala has been developed for the treatment of a range of IL-5 mediated diseases associated with type 2 inflammation
  • HIGHLIGHTS OF PRESCRIBING INFORMATION • NUCALA. - GSKpro
    NUCALA is indicated for the add-on maintenance treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in adult patients aged 18 years and older with inadequate response to nasal corticosteroids
  • Mepolizumab - Wikipedia
    Mepolizumab, sold under the brand name Nucala by GlaxoSmithKline, is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome (HES) [5]
  • label - accessdata. fda. gov
    NUCALA is indicated for the add-on maintenance treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in adult patients aged 18 years and older with inadequate response to nasal
  • Nucala: Uses, How it works, Dosage, and More - Healthline
    Learn about the uses, dosage, price and more for Nucala (mepolizumab), a prescription injection that treats asthma and other conditions in adults and some children




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer